Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Betsy J Barnes

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Current Rheumatology Reports|January 16, 2019
Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLEBetsy J Barnes
Journal of Leukocyte Biology|October 2, 2013
Editorial: are regulatory B10 cells a viable target for autoimmune diseases?Betsy J Barnes
Molecular and Cellular Biology|January 18, 2018
Corrected and Republished from: The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein StabilityJustyna Korczeniewska, Betsy J Barnes
Expert Review of Anticancer Therapy|June 9, 2006
Interferon regulatory factor-5-regulated pathways as a target for colorectal cancer therapeuticsGoudong Hu, Betsy J Barnes
The Journal of Biological Chemistry|November 26, 2008
IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathwayGuodong Hu, Betsy J Barnes
Cytokine|May 28, 2019
Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesisBharati Matta, Betsy J Barnes
Molecular and Cellular Biology|January 1, 2013
The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stabilityJustyna Korczeniewska, Betsy J Barnes
Frontiers in Immunology|September 26, 2013
Bioinformatics analysis of the factors controlling type I IFN gene expression in autoimmune disease and virus-induced immunityDi Feng, Betsy J Barnes
Molecular and Cellular Biology|November 30, 2017
Retraction for Korczeniewska and Barnes, "The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein Stability"Justyna Korczeniewska, Betsy J Barnes
Clinical Immunology (Orlando, Fla.)|March 29, 2014
B cell transcription factors: Potential new therapeutic targets for SLESaurav De, Betsy J Barnes
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Current Rheumatology Reports|January 16, 2019
Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLEBetsy J Barnes
Journal of Leukocyte Biology|October 2, 2013
Editorial: are regulatory B10 cells a viable target for autoimmune diseases?Betsy J Barnes
Molecular and Cellular Biology|January 18, 2018
Corrected and Republished from: The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein StabilityJustyna Korczeniewska, Betsy J Barnes
Expert Review of Anticancer Therapy|June 9, 2006
Interferon regulatory factor-5-regulated pathways as a target for colorectal cancer therapeuticsGoudong Hu, Betsy J Barnes
The Journal of Biological Chemistry|November 26, 2008
IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathwayGuodong Hu, Betsy J Barnes
Cytokine|May 28, 2019
Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesisBharati Matta, Betsy J Barnes
Molecular and Cellular Biology|January 1, 2013
The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stabilityJustyna Korczeniewska, Betsy J Barnes
Frontiers in Immunology|September 26, 2013
Bioinformatics analysis of the factors controlling type I IFN gene expression in autoimmune disease and virus-induced immunityDi Feng, Betsy J Barnes
Molecular and Cellular Biology|November 30, 2017
Retraction for Korczeniewska and Barnes, "The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein Stability"Justyna Korczeniewska, Betsy J Barnes
Clinical Immunology (Orlando, Fla.)|March 29, 2014
B cell transcription factors: Potential new therapeutic targets for SLESaurav De, Betsy J Barnes
Pageof 9